Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant VWF antibody (AA 1815-1939) (CF®405S)

This anti-VWF antibody is a Mouse Monoclonal antibody detecting VWF in WB, IHC and IHC (fp). Suitable for Human.
Catalog No. ABIN7661973

Quick Overview for Recombinant VWF antibody (AA 1815-1939) (CF®405S) (ABIN7661973)

Target

See all VWF Antibodies
VWF (Von Willebrand Factor (VWF))

Antibody Type

Recombinant Antibody

Reactivity

  • 225
  • 44
  • 32
  • 12
  • 7
  • 6
  • 2
  • 1
Human

Host

  • 132
  • 131
  • 13
  • 7
  • 1
  • 1
  • 1
Mouse

Clonality

  • 158
  • 123
  • 2
Monoclonal

Conjugate

  • 134
  • 29
  • 18
  • 11
  • 9
  • 9
  • 9
  • 9
  • 9
  • 8
  • 7
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This VWF antibody is conjugated to CF®405S

Application

  • 187
  • 161
  • 80
  • 74
  • 63
  • 55
  • 49
  • 46
  • 25
  • 16
  • 16
  • 15
  • 9
  • 9
  • 8
  • 6
  • 6
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp))

Clone

RVWF-1465
  • Binding Specificity

    • 54
    • 22
    • 16
    • 11
    • 9
    • 8
    • 6
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1815-1939

    Purpose

    von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker) (rVWF/1465), CF405S conjugate

    Characteristics

    von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen.Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Immunogen

    Recombinant fragment of human vWF protein (aa1815-1939)

    Isotype

    IgG1, kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Positive Control: HUVEC cells. Tonsil.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.1 mg/mL

    Buffer

    PBS, 0.1 % BSA, 0.05 % azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Protect from light

    Storage

    4 °C

    Storage Comment

    Stable at room temperature or 37°C for 7 days.

    Protect from light

    Store at 2 to 8°C. Protect fluorescent conjugates from light

    Expiry Date

    24 months
  • Target

    VWF (Von Willebrand Factor (VWF))

    Alternative Name

    Von Willebrand Factor

    Background

    Synonyms: Coagulation Factor VIII, Factor VIII Related Antigen, F8VWF, von Willebrand Antigen 2, von Willebrand Disease (vWD)

    Gene Symbol: VWF

    Tissue Expression: Endothelial cells

    Molecular Weight

    250 kDa

    Gene ID

    7450

    UniProt

    P04275
You are here:
Chat with us!